CleanWnd®

A new development in wound Debridement and Cleansing

For Acute and Chronic Wounds

Contains Sodium Hyaluronate, Phospholipids and Aloe Vera

Click here for the product details and to get in touch

To get in touch and for more information on the Out of Hours Burns Service we provide please click here:

To find out more about Joint Operations and what we do in Orthopaedics and Sports Medicine click here:

Latest News

Using dHACM allografts in the treatment of chronic wounds

Bill Tettelbach talks about using Amniotic Tissue in the treatment of chronic wounds. This article is based on a talk given at the Wounds UK annual conference in Harrogate, UK, on November 7, 2018. for the online version please go to:... read more

Placental Based Allografts Accredited On-Demand Webcast Series

Placental Based Allografts are now being acknowledged more and more as a potential treatment in non healing and hard to heal wounds where conventional woundcare strategies have failed. These webcasts will help you understand more about how this technology fits in.... read more

EpiFix – where does it fit in?

With new technologies the question is often asked, where does it fit in? With the case of Amniotic Tissue and EpiFix® and to ensure the NHS gets best value for money this needs to be carefully considered. Whilst the evidence is very strong for EpiFix it clearly has to... read more

The use of Epiprotect®, an advanced wound dressing, to heal paediatric patients with burns: a pilot study – Giancarlodelli Santi Alessandro Borgognone

An opportunity to take an early look at a new pilot series looking at EpiProtect and Nexobrid in Paediatrics A final version is yet to be published but we get a chance to look at an interesting study from Giancarlo and Alessandro Borgognone in Italy. Highlights • A... read more

Microbial Cellulose (Epiprotect®) Burns Dressings in Young Children: An Initial Experience – Children’s Burns and Plastics, Nottingham Children’s Hospital, Nottingham University Hospitals NHS Trust

The team at Children’s Burns and Plastics,Nottingham Children’s Hospital were the first to try and adopt EpiProtect® here in the UK, They are also the first to treat patients with a median age of 18 months which is a an exciting development in the treatment of burns... read more

EpiFix – Tracy’s Story

Attendees at the recent Charing Cross Symposium in London had the opportunity to hear Leanne Atkin, Vascular Nurse Consultant from Yorkshire (pictured), present on EpiFix as a credible option for hard to heal venous ulcers. As part of her presentation, Leanne spoke... read more

A case series using DHACM allograft in the treatment of hard to heal wounds

This early case series from the Welsh Wound Innovation Centre looks at some of the first patients in the UK to receive EpiFix®, our amniotic tissue for use in acute and chronic wounds. This early data looks at a range of patients with wounds spanning 6 months, 12... read more

New Level 1 study – EpiFix demonstrates Superior healing rates in DFUs vs SOC

EpiFix has demonstrated in previous studies very high rates of healing, with the original study showing 90%+ rates of healing in DFU wounds and 71% in VLU wounds. With studies looking at long term follow up and the overall time to closure using weekly applications v... read more

EpiProtect overview and introduction

An introduction to EpiProtect® During this years BBA conference here in the UK, we launched EpiProtect, a new and innovative burn dressing from Sweden. Developed in conjunction with one of the major burns units in Sweden, EpiProtect is a unique take on cellulose with... read more

Launch of Regen Medical, part of the Joint Operations family

We are delighted to announce the launch of Regen Medical, a new and integral part of the Joint Operations family. Our dedicated Regen Medical team was formed to continue the commitment from Joint Operations to support its customers within the Burns, Wound Healing,... read more

Joint Operations awarded UK distribution rights for Lipogems

Joint Operations is delighted to have been awarded UK distribution rights for Lipogems. Lipogems is a unique system intended for the harvesting of adipose tissue and the closed-loop processing and transferring of autologous tissue. This non-expanded and... read more

Acellular Dermal Allograft – Key facts on biocompatibility and growth factors that make for an ideal scaffold

Allograft (Human) Acellular Dermal Matrix represents a viable option in both tissue replacement and reconstruction. The following article looks at two publications from the AlloSource Basic Science series. Acellular dermal matrices can be used to successfully replace... read more

Joint Operations lends support to Swindon’s Christmas Care project

Joint Operations are proud to be supporting Christmas Care this festive season. Christmas Care is based in Swindon, at Buckhurst Park Community Centre, and will be open 24 hours a day from Christmas Eve until the morning of 28th December. The project will provide... read more

5 reasons to change what you do with Burn Care skin

Cryopreserved burn care skin is normally reserved for larger burns. Working with our partners AlloSource we have found ways to help make the GOLD STANDARD in burn care more accessible, not just for larger burns but for use in smaller burns too. As one of the... read more

Joint Operations attending the first Educational Course of the European Burns Association

Joint Operations are proud to be attending EBA 2016, the first show of this kind. Over the course of the show, we will be exhibiting a number of innovative and unique products within the fields of Burns, Plastics and Reconstruction. Our unique and wide range includes... read more

Joint Operations welcomes two local Apprentices

The last few months have seen many exciting developments at Joint Operations, a Swindon based medical device distribution business focussing on Joint Preservation, Extremities and Regenerative Medicine. June saw the 1st birthday celebration of the company’s... read more

Regenerative Medicine – The Future of Plastic Surgery

What is regenerative medicine? Regenerative medicine is the science of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal form and function. This broadly encompasses the use of cells, tissues, drugs, synthetic... read more

HTA licence approved for Joint Operations

HTA licence approved for Joint Operations. Joint Operations operates in several specialities which utilise human tissue for repair and regeneration. Primarily these include Orthopaedics, Burns and Plastics and Cardio Thoracic surgery. As such we are excited to... read more

Tweets by @regenmedicalltd